Advertisement
BMC Biotechnology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
A recent article published in BMC Biotechnology explores the potential of transgenic chicken as a bioreactor for cost-effective production of pure, high quality, biologically active protein for therapeutics. See the social media coverage here.
BMC Biotechnology has launched two new sections: Biomaterials section led by Prof. Hyung Joon Cha, Pohang University of Science and Technology, Republic of Korea; Systems and synthetic biology section led by Prof. Ting Lu, University of Illinois at Urbana-Champaign, USA.
Both sections are now open for submissions.
BMC Biotechnology is currently accepting submissions to a thematic series entitled "Genome editing technology and applications in animals and plants".
Editor
Assistant Editor
Section Editors
BMC Biotechnology advocates complete and transparent reporting of research. The BMC minimum standards of reporting checklist is intended as a tool for authors to transparently describe their research and ensure reproducibility. We encourage our authors to adhere to these standards when preparing their manuscript.
Research Data Support is an optional Springer Nature service available to researchers who have datasets they want to make easier to cite, share and find. Learn more about this service and the many benefits of making your data publicly available.
Peter J. Punt, PhD is Chief Technology Officer of Dutch DNA Biotech BV, a fungal biotechnology technology provider and contract research company situated in the Netherlands. In 2008 he was appointed at Leiden University in the chair of Industrial Biotechnology He joined BMC Biotechnology as a Section Editor in 2012.
21 August 2019
Advertisement
Citation Impact
2.303 - 2-year Impact Factor
2.861 - 5-year Impact Factor
0.916 - Source Normalized Impact per Paper (SNIP)
1.006 - SCImago Journal Rank (SJR)
Usage
624,784 Downloads
165 Altmetric Mentions
Advertisement
